History & Growth

Square Pharmaceuticals Ltd.

Milestone of excellence

1958

Debut of Square Pharmaceuticals as a Partnership Firm.

  • 1964

    Converted into a Private Limited Company

  • 1974

    Technical collaboration with Janseen Pharmaceuticals, Belgium, a subsidiary of Johnson & Johonson Intl, USA.

  • 1985

    Achived market leadership in the Pharmaceuticals market in Bangladesh among all the national and multinational companies

  • 1987

    Pioneer in Pharmaceutical export from Bangladesh

  • 1991

    Converted into a Public Limited Company

  • 1994

    Initial Public Offering of Square Pharmaceutical's shares

  • 1995

    Chemical Division starts production of pharmaceutical bulk products(API)

  • 1997

    Won the National Export Trophy for exporting pharmaceuticals

  • 2001

    UK FDA/UK MHRA standard new Pharmaceutical factory goes into operation built under the supervision of Bovis Lend Lease, UK

  • 2002

    Square enlisted as INICEF's global supplier

  • 2005

    Inception of Square Harbal & Nutraceuticals Ltd.

  • 2007

    Square Pharmaceuticals Ltd. Dhaka unit gets the UK MHRA approval

  • 2009

    Starts manufacturing of insulin, hormone & steroid products maintaining quality standards of US FDA, MHRA in dedicated manufacturing facility complying with the cGMP of WHO

  • 2013

    Samson H Chowdhury "Centre of Excellence" starts its journey

  • 2014

    Liquid Formulation Unit of Square Pharmaceuticals Ltd. Pabna Site gets PIC/S (Pharmaceutical Inspection Co-operation Scheme) approval.

  • 2015

    Square Pharmaceuticals gets USFDA's approval

  • 2016

    Dhaka Site's solid dosage unit and Metered Dose Inhaler unit get MCC (Medicines Control Council), South Africa and PIC/S approval.

1958

Debut of Square Pharmaceuticals as a Partnership Firm.

  • 1964

    Converted into a Private Limited Company

  • 1974

    Technical collaboration with Janseen Pharmaceuticals, Belgium, a subsidiary of Johnson & Johonson Intl, USA.

  • 1985

    Achived market leadership in the Pharmaceuticals market in Bangladesh among all the national and multinational companies

  • 1987

    Pioneer in Pharmaceutical export from Bangladesh

  • 1991

    Converted into a Public Limited Company

  • 1994

    Initial Public Offering of Square Pharmaceutical's shares

  • 1995

    Chemical Division starts production of pharmaceutical bulk products(API)

  • 1997

    Won the National Export Trophy for exporting pharmaceuticals

  • 2001

    UK FDA/UK MHRA standard new Pharmaceutical factory goes into operation built under the supervision of Bovis Lend Lease, UK

  • 2002

    Square enlisted as INICEF's global supplier

  • 2005

    Inception of Square Harbal & Nutraceuticals Ltd.

  • 2007

    Square Pharmaceuticals Ltd. Dhaka unit gets the UK MHRA approval

  • 2009

    Starts manufacturing of insulin, hormone & steroid products maintaining quality standards of US FDA, MHRA in dedicated manufacturing facility complying with the cGMP of WHO

  • 2013

    Samson H Chowdhury "Centre of Excellence" starts its journey

  • 2014

    Liquid Formulation Unit of Square Pharmaceuticals Ltd. Pabna Site gets PIC/S (Pharmaceutical Inspection Co-operation Scheme) approval.

  • 2015

    Square Pharmaceuticals gets USFDA's approval

  • 2016

    Dhaka Site's solid dosage unit and Metered Dose Inhaler unit get MCC (Medicines Control Council), South Africa and PIC/S approval.